Literature DB >> 9787154

Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential.

M Neipp1, T Zorina, M A Domenick, B G Exner, S T Ildstad.   

Abstract

We have previously identified a cellular population in murine bone marrow that facilitates engraftment of highly purified hematopoietic stem cells (HSC) across major histocompatibility complex (MHC) barriers without causing graft-versus-host disease. Here we investigated the effect of flt3 ligand (FL) and granulocyte colony-stimulating factor (G-CSF) on the mobilization of facilitating cells (FC) and HSC into peripheral blood (PB). Mice were injected with FL alone (day 1 to 10), G-CSF alone (day 4 to 10), or both in combination. The number of FC (CD8(+)/alpha betaTCR-/gamma deltaTCR-) and HSC (lineage-/Sca-1(+)/c-kit+) was assessed daily by flow cytometry. Lethally irradiated allogeneic mice were reconstituted with PB mononuclear cells (PBMC). FL and G-CSF showed a highly significant synergy on the mobilization of FC and HSC. The peak efficiency for mobilization of FC (21-fold increase) and HSC (200-fold increase) was reached on day 10. Our data further suggest that the proliferation of FC and HSC induced by FL in addition to the mobilizing effect mediated by G-CSF might be responsible for the observed synergy of both growth factors. Finally, the engraftment potential of PBMC mobilized with FL and G-CSF or FL alone was superior to PBMC obtained from animals treated with G-CSF alone. Experiments comparing the engraftment potential of day 7 and day 10 mobilized PBMC indicate that day 10, during which both FC and HSC reached their maximum, might be the ideal time point for the collection of both populations. Copyright 1998 by The American Society of Hematology

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787154

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: potential involvement of very small embryonic-like cells.

Authors:  Yiming Huang; Magda Kucia; Lala-Rukh Hussain; Yujie Wen; Hong Xu; Jun Yan; Mariusz Z Ratajczak; Suzanne T Ildstad
Journal:  Transplantation       Date:  2010-03-27       Impact factor: 4.939

2.  Single-cell analyses reveal the clonal and molecular aetiology of Flt3L-induced emergency dendritic cell development.

Authors:  Dawn S Lin; Luyi Tian; Sara Tomei; Daniela Amann-Zalcenstein; Tracey M Baldwin; Tom S Weber; Jaring Schreuder; Olivia J Stonehouse; Jai Rautela; Nicholas D Huntington; Samir Taoudi; Matthew E Ritchie; Philip D Hodgkin; Ashley P Ng; Stephen L Nutt; Shalin H Naik
Journal:  Nat Cell Biol       Date:  2021-03-01       Impact factor: 28.824

3.  The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in mice.

Authors:  Erik Ames; Salif Harouna; Colin Meyer; Lisbeth A Welniak; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-17       Impact factor: 5.742

4.  FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche.

Authors:  Kirsten M Williams; Amber R Moore; Philip J Lucas; Juin Wang; Catherine V Bare; Ronald E Gress
Journal:  Exp Hematol       Date:  2017-05-26       Impact factor: 3.084

Review 5.  Stem cell-based therapeutic applications in retinal degenerative diseases.

Authors:  Yiming Huang; Volker Enzmann; Suzanne T Ildstad
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

6.  Expression, purification and characterization of the extracellular domain of human Flt3 ligand in Escherichia coli.

Authors:  Xingcheng Zhao; Ping Zhang; Qiang Liu; Fei He; Lei Feng; Hua Han
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

7.  The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up.

Authors:  Santosh K Sanganalmath; Adam B Stein; Yiru Guo; Sumit Tiwari; Greg Hunt; Robert J Vincent; Yiming Huang; Arash Rezazadeh; Suzanne T Ildstad; Buddhadeb Dawn; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2009-07-16       Impact factor: 5.000

8.  Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.

Authors:  Dina N Rahhal; Hong Xu; Wei-Chao Huang; Shengli Wu; Yujie Wen; Yiming Huang; Suzanne T Ildstad
Journal:  Transplantation       Date:  2009-09-27       Impact factor: 4.939

9.  SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.

Authors:  Caroline Desponts; Amy L Hazen; Kim H T Paraiso; William G Kerr
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

10.  Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.

Authors:  Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Yiming Huang; Adam B Stein; Greg Hunt; Sumit Tiwari; Jai Varma; Yan Gu; Sumanth D Prabhu; Jan Kajstura; Piero Anversa; Suzanne T Ildstad; Roberto Bolli
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.